These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 22347701)

  • 21. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Emerging trends in contract research industry in India.
    Drabu S; Gupta A; Bhadauria A
    Contemp Clin Trials; 2010 Sep; 31(5):419-22. PubMed ID: 20609394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacovigilance during the pre-approval phases: an evolving pharmaceutical industry model in response to ICH E2E, CIOMS VI, FDA and EMEA/CHMP risk-management guidelines.
    Hartford CG; Petchel KS; Mickail H; Perez-Gutthann S; McHale M; Grana JM; Marquez P
    Drug Saf; 2006; 29(8):657-73. PubMed ID: 16872240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Real world evidence (RWE) - a disruptive innovation or the quiet evolution of medical evidence generation?
    Khosla S; White R; Medina J; Ouwens M; Emmas C; Koder T; Male G; Leonard S
    F1000Res; 2018; 7():111. PubMed ID: 30026923
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transparent collaboration between industry and academia can serve unmet patient need and contribute to reproductive public health.
    D'Hooghe T
    Hum Reprod; 2017 Aug; 32(8):1549-1555. PubMed ID: 28854594
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Historical sketch of modern pharmaceutical science and technology (Part 4). Post World War II 50 years].
    Yamakawa K
    Yakushigaku Zasshi; 1995; 30(2):75-90. PubMed ID: 11613536
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmaceutical industry-led partnerships focused on addressing the global burden of non-communicable diseases: a review of Access Accelerated.
    Umeh CA; Rockers PC; Laing RO; Wagh O; Wirtz VJ
    Public Health; 2020 Apr; 181():73-79. PubMed ID: 31958672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Measuring student satisfaction as the first assessment of the Program of Combined Studies in Medicine, an MD/PhD-like program of the Faculty of Medicine, National Autonomous University of Mexico.
    Martínez-Flisser G; Flisser A; Castro-Guerrero MA; Plett-Torres T
    BMC Med Educ; 2020 Nov; 20(1):446. PubMed ID: 33213436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [The relationship between medicine and medical suppliers].
    Heerlein A
    Rev Med Chil; 2014 Mar; 142(3):361-7. PubMed ID: 25052274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Introducing new contraceptives.
    Segal SJ; Coutinho E
    Draper Fund Rep; 1986 Dec; (15):27-32. PubMed ID: 12341234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Attitudes and practices of medical graduates in Delhi towards gifts from the pharmaceutical industry.
    Sharma V; Aggarwal S; Singh H; Garg S; Sharma A; Sharma R
    Indian J Med Ethics; 2010; 7(4):223-5. PubMed ID: 22106572
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [An analysis of the pharmaceuticals market in Vietnam].
    Simonet D
    Sante; 2001; 11(3):155-60. PubMed ID: 11641078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors affecting the acceptance of expert advice.
    Van Swol LM; Sniezek JA
    Br J Soc Psychol; 2005 Sep; 44(Pt 3):443-61. PubMed ID: 16238848
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Conflict of interest regarding clinical physicians' relationship with pharmaceutical industry and medical education].
    Miyata Y
    Seishin Shinkeigaku Zasshi; 2010; 112(11):1136-45. PubMed ID: 21226250
    [TBL] [Abstract][Full Text] [Related]  

  • 35. ISPOR, the FDA, and the Evolving Regulatory Science of Medical Device Products.
    O'Neill T; Miksad R; Miller D; Maloney L; John A; Hiller C; Hornberger J
    Value Health; 2019 Jul; 22(7):754-761. PubMed ID: 31277820
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world?
    Guerin PJ; Singh-Phulgenda S; Strub-Wourgaft N
    F1000Res; 2020; 9():225. PubMed ID: 32566139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Big-pharmaceuticalisation: clinical trials and Contract Research Organisations in India.
    Sariola S; Ravindran D; Kumar A; Jeffery R
    Soc Sci Med; 2015 Apr; 131():239-46. PubMed ID: 25476783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Control of chemicals in Sweden: an example of misuse of the "precautionary principle".
    Nilsson R
    Ecotoxicol Environ Saf; 2004 Feb; 57(2):107-17. PubMed ID: 14759655
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Internet and drug safety: what are the implications for pharmacovigilance?
    Cobert B; Silvey J
    Drug Saf; 1999 Feb; 20(2):95-107. PubMed ID: 10082068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Survey of Key Opinion Leaders to Support Curriculum Development in Advanced Medical Science Liaison Training.
    Moss RJ; Smith EB; Anderson G; Rozenfeld V; Evangelista C; Trahey C; Venuti C; Weiner EJ
    Ther Innov Regul Sci; 2015 Jan; 49(1):45-49. PubMed ID: 30222457
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.